Research aiming to develop a cure for HIV infection (or induce long-term remission) can involve clinical trials and observational studies in which people living with HIV are asked to temporarily interrupt antiretroviral therapy (ART). The term used is analytical treatment interruption (ATI).
There are uncertainties regarding the safety of ATIs, and ongoing debates about how to design this research so that any risks to participants are minimized. For some ATIs, there are also concerns about the potential for an increased risk of HIV transmission to sexual partners of trial participants.
Treatment Action Group is conducting an online survey to solicit the opinions of HIV treatment and research advocates on how to approach the use of ATIs in HIV cure-related research. (You’ll find additional details and contact information on the survey form.)
The survey will take 15-45 minutes to complete.
The survey response deadline is Friday, June 22, 2018.
To complete the survey, click here.